A BMI of 30 to 34.9 plus at least one of the following: Diastolic heart failure Uncontrolled high blood pressure Chronic kidney disease at stage 3a or higher Prediabetes A previous heart attack or stroke Blocked arteries in the legs or arms with symptoms A BMI of 27 to 29.9 and at least one of the following: Prediabetes A previous heart attack or stroke Blocked arteries in the legs or arms with symptoms Patients who are already on GLP-1s for other conditions, such as diabetes or liver disease, would stay on their original coverage under their Part D drug plan, Dr
Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk
The most commonly used types of GLP-1 receptor agonists are semaglutide and tirzepatide, which are used to treat type 2 diabetes and aid weight loss
It may show up as thinking about your next meal immediately after eating, replaying food choices over and over in your head, or even feeling pulled towards food when you know youre not hungry
& Huang, Y
If redness spreads beyond 2 inches from the injection site, lasts more than 48 hours, or is accompanied by warmth, swelling, or drainage, contact a healthcare provider